The Weekly Litigation News Digest is now live. Subscribe now

Rapamycin Derivative For The Treatment Of A Solid Tumor Associated With Deregulated Angiogenesis - EP3351246

The patent EP3351246 was granted to Novartis on Sep 18, 2019. The application was originally filed on Feb 18, 2002 under application number EP18155644A. The patent is currently recorded with a legal status of "Revoked".

EP3351246

NOVARTIS
Application Number
EP18155644A
Filing Date
Feb 18, 2002
Status
Revoked
Oct 23, 2023
Publication Date
Sep 18, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (9)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ARROW GENERIQUESFeb 24, 2020TRIPOZADMISSIBLE
TEVA PHARMACEUTICALSFeb 22, 2020AUGUST DEBOUZYADMISSIBLE
GENERICS UKFeb 21, 2020ELKINGTON AND FIFEADMISSIBLE
DR REDDYS LABORATORIES BETAPHARM ARZNEIMITTELJan 29, 2020MAIWALDADMISSIBLE
ZENTIVA PHARMASep 16, 2019BIRD & BIRDADMISSIBLE
ACCORD HEALTHCAREJul 31, 2019PLOUGMANN VINGTOFTWITHDRAWN
ETHYPHARMJul 3, 2019LLRADMISSIBLE
BIOGARANJul 1, 2019CASALONGAADMISSIBLE
STADA ARZNEIMITTELMay 23, 2019HAMM & WITTKOPPADMISSIBLE

Patent Citations (65) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0296110
DESCRIPTIONEP0520722
DESCRIPTIONEP0564409
DESCRIPTIONEP0566226
DESCRIPTIONEP0769947
DESCRIPTIONEP0787722
DESCRIPTIONEP0837063
DESCRIPTIONGB2177700
DESCRIPTIONUS4100274
DESCRIPTIONUS4636505
DESCRIPTIONUS4659516
DESCRIPTIONUS5010099
DESCRIPTIONUS5362718
DESCRIPTIONUS5747498
DESCRIPTIONUS5843901
DESCRIPTIONWO0009495
DESCRIPTIONWO0027819
DESCRIPTIONWO0027820
DESCRIPTIONWO0037502
DESCRIPTIONWO0059509
DESCRIPTIONWO9409010
DESCRIPTIONWO9410202
DESCRIPTIONWO9503283
DESCRIPTIONWO9516691
DESCRIPTIONWO9630347
DESCRIPTIONWO9633980
DESCRIPTIONWO9641807
DESCRIPTIONWO9702266
DESCRIPTIONWO9730034
DESCRIPTIONWO9738983
DESCRIPTIONWO9749688
DESCRIPTIONWO9810767
DESCRIPTIONWO9811223
DESCRIPTIONWO9835958
DESCRIPTIONWO9903854
DESCRIPTIONWO9917804
EXAMINATIONUS5206018
OPPOSITIONEP0663916
OPPOSITIONEP1363267
OPPOSITIONEP2269603
OPPOSITIONEP2783686
OPPOSITIONEP3143995
OPPOSITIONEP3406249
OPPOSITIONGB104072
OPPOSITIONGB124957
OPPOSITIONGB2177700
OPPOSITIONUS5066493
OPPOSITIONUS5206018
OPPOSITIONUS5922730
OPPOSITIONWO0069467
OPPOSITIONWO0112633
OPPOSITIONWO0151049
OPPOSITIONWO0164193
OPPOSITIONWO02066019
OPPOSITIONWO02080975
OPPOSITIONWO9409010
OPPOSITIONWO9747317
OTHEREP1363627
OTHEREP3406249
OTHERWO0069467
OTHERWO02066019
OTHERWO9747317
SEARCHWO0151049
SEARCHWO9409010
SEARCHWO9747317

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents